Peer Reviewed
Perspectives
Psychological impact of hypoglycaemia: the hidden depths of the type 2 diabetes iceberg
Recent articles on:
Diabetes type 2
Diabetes type 2
Abstract
Hypoglycaemia is a concern to many people with type 2 diabetes, particularly as it is the most common side effect of some glucose-lowering therapies. Although the immediate risks to the individual are evident and usually manageable, the psychological impact is often less visible but more pervasive, with long-term implications for both self-management and quality of life.
Key Points
- Hypoglycaemia is a significant side effect of insulin therapy and some oral glucose-lowering agents (e.g. sulfonylureas).
- Hypoglycaemia is often thought to be associated with type 1 diabetes only; however, twice as many people with type 2 diabetes use insulin in Australia than people with type 1 diabetes, and many more use sulfonylureas.
- Experiencing hypoglycaemia can lead to fear of hypoglycaemia and reduced quality of life.
- People with type 2 diabetes often apply compensatory behaviours to reduce their risk of hypoglycaemia and their fear of it. These behaviours include reducing and/or omitting medication doses, avoiding physical activities and more frequent snacking.
- It is important for healthcare professionals to show respect, sensitivity and support to enable the person with diabetes to talk openly about their experiences and concerns regarding hypoglycaemia.
- With specialist support, people with diabetes can address their fear of hypoglycaemia without compromising their long-term diabetes outcomes.
Picture credit: © Bestdesigns/iStockphoto.
Get full access
Buy this article
Single article purchases are temporarily unavailable due to site maintenance.
If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.
Thank you for your patience and understanding.
Already a subscriber? Login here.